Cefepime – Injection products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
| Minimum Inhibitory | Disk Diffusion | ||||
|---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | ≤2 | 4-8a | ≥16 | ≥25 | 19-24a | ≤18 |
Pseudomonas aeruginosa b | ≤8 | - | ≥16 | ≥18 | - | ≤17 |
Streptococcus pneumoniae | M100 standard is recognized | - | - | - | ||
Streptococcus spp β- Hemolytic Group | M100 standard is recognized | |||||
Streptococcus spp Viridans Group | M100 standard is recognized | |||||
S = Susceptible; I = Intermediate; R = Resistant
a For isolates of Enterobacteriaceae with intermediate susceptibility, use a dose of 2g every 8 hours in patients with normal renal function.
b For Pseudomonas aeruginosa, use a dose of 2 g IV every 8 hours in patients with normal renal function.
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp
Other Non-Enterobacteriaceae
Haemophilus influenzae and Haemophilus parainfluenzae
Neisseria gonorrhoeae